News Go

News & articles

Glaucoma Surgery Market 2017 -Identify Opportunities and Challenges-CAGR 7.9% during forecasted period 2017-2023.


Market Research Future published new report, titled “Glaucoma Surgery – Market Research Report: Global Forecast to 2027”.

Market Synopsis for Global Glaucoma Surgery Market:

Market Scenario:

Glaucoma is refer to a condition which causes blindness. It is a chronic and permanent disorder whose prevalence’s is increasing with increasing age. Beside this different diseases like diabetes and deficiency of vitamins can also cause this disease. The major driving factor for the growth of this market are increasing aging population across the globe and increasing prevalence of diabetes. Changing lifestyle and unhealthy food has given a push for the growth of this market. On the other hand, preference of minimum surgery and high cost of the surgical treatment can hamper the growth of the market.

Global glaucoma surgery market is expected to grow at a CAGR of 7.9% during forecasted period of 2017-2023.


Global glaucoma surgery market is segmented on the basis of target into trabecular meshwork, suprachoroidal space and others. On the basis of type of surgery it is segmented into angle closure glaucoma surgery, aqueous shunt surgery, laser surgery and other and on the basis of end user the market is segmented into hospital, ambulatory surgery centers and other.

Key Players for global Glaucoma Surgery market:

Novartis AG (Switzerland), Allergan (US), Merck & Co., Inc. (US), Abbott (US), Akorn, Inc. (US), Teva Pharmaceuticals (US), Bausch & Lomb (US), Pfizer, Santen (Japan), Carl Zeiss Meditec (Germany),  Alcon (US), Ellex Medical Lasers (Australia), Lumenis (US), Topcon Medical Systems (US), Nidek (US), OPHTEC (US), Optos (US), Accutome (US), AqueSys (Taiwan), Canon (Japan), Essilor (France), Iridex Corporation (US)


Market Assessment:

The report for global glaucoma surgery market of Market Research Future comprises of extensive primary research…

Read the full article from the Source…

Back to Top